{"id":41992,"date":"2020-05-21T13:59:35","date_gmt":"2020-05-21T17:59:35","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=41992"},"modified":"2023-06-06T17:53:30","modified_gmt":"2023-06-06T21:53:30","slug":"use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/","title":{"rendered":"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement"},"content":{"rendered":"<figure id=\"attachment_3504\" class=\"thumbnail wp-caption alignright\" style=\"width: 226px\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-3504\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-216x300.png\" alt=\"dr-jonathan-parr\" width=\"216\" height=\"300\" srcset=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-216x300.png 216w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-301x419.png 301w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png 350w\" sizes=\"auto, (max-width: 216px) 100vw, 216px\" \/><figcaption class=\"caption wp-caption-text\"><span class=\"discreet\">Jonathan Parr, MD, MPH<\/span><\/figcaption><\/figure>\n<p><a href=\"https:\/\/www.med.unc.edu\/medicine\/directory\/jonathan-parr-md-mph\/\"><strong>Jonathan Parr<\/strong><\/a>, MD, MPH, assistant professor of medicine in the division of infectious diseases, was interviewed by the\u00a0<a href=\"https:\/\/www.charlotteobserver.com\/news\/local\/article242868446.html\">Charlotte Observer<\/a> regarding the use of arthritis drug toxilizumab in treating COVID-19 and a <a href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2020.05.13.20100404v1\">case report<\/a> that indicates &#8220;clear evidence of clinical improvement\u201d is limited.<\/p>\n<p>This study \u201cmade us rethink our use of the drug,\u201d says Parr in the news story. \u201cMuch of the medical literature we\u2019re using to base our clinical decisions on is rapidly evolving. All of us clinicians are hungry for evidence to guide our decision making. What we really need are randomized controlled trials.\u201d<\/p>\n<p>The article also references a Cone Health study that used a different approach and showed the drug does offer benefits. Parr said &#8220;the two studies could not be compared because they have very different designs.&#8221;<\/p>\n<p>Other authors from the department of medicine include <strong>Shannon Carson<\/strong>, MD, <strong>Billy Fischer<\/strong>, MD, <strong>Joseph Eron<\/strong>, MD, and <strong>Cynthia Gay<\/strong>, MD. Read the abstract <a href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2020.05.13.20100404v1\"><strong>here<\/strong><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jonathan Parr, MD, MPH, assistant professor of medicine in the division of infectious diseases, was interviewed by the\u00a0Charlotte Observer regarding the use of arthritis drug toxilizumab in treating COVID-19 and a case report that indicates &#8220;clear evidence of clinical improvement\u201d is limited. This study \u201cmade us rethink our use of the drug,\u201d says Parr in &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\" aria-label=\"Read more about Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement\">Read more<\/a><\/p>\n","protected":false},"author":69419,"featured_media":3504,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[100,2],"tags":[629],"class_list":["post-41992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infectious-diseases","category-news","tag-629","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"Jonathan Parr, MD, MPH, assistant professor of medicine in the division of infectious diseases, was interviewed by the\u00a0Charlotte Observer regarding the use of arthritis drug toxilizumab in treating COVID-19 and a case report that indicates &#8220;clear evidence of clinical improvement\u201d is limited. This study \u201cmade us rethink our use of the drug,\u201d says Parr in &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-21T17:59:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T21:53:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"487\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Kim Morris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Morris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\"},\"author\":{\"name\":\"Kim Morris\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"headline\":\"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement\",\"datePublished\":\"2020-05-21T17:59:35+00:00\",\"dateModified\":\"2023-06-06T21:53:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\"},\"wordCount\":180,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png\",\"keywords\":[\"2020\"],\"articleSection\":[\"Infectious Diseases\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\",\"name\":\"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png\",\"datePublished\":\"2020-05-21T17:59:35+00:00\",\"dateModified\":\"2023-06-06T21:53:30+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png\",\"width\":350,\"height\":487,\"caption\":\"Jonathan Parr, MD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\",\"name\":\"Kim Morris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"caption\":\"Kim Morris\"},\"description\":\"Medicine - Dept of\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/","og_locale":"en_US","og_type":"article","og_title":"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement | Department of Medicine","og_description":"Jonathan Parr, MD, MPH, assistant professor of medicine in the division of infectious diseases, was interviewed by the\u00a0Charlotte Observer regarding the use of arthritis drug toxilizumab in treating COVID-19 and a case report that indicates &#8220;clear evidence of clinical improvement\u201d is limited. This study \u201cmade us rethink our use of the drug,\u201d says Parr in &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2020-05-21T17:59:35+00:00","article_modified_time":"2023-06-06T21:53:30+00:00","og_image":[{"width":350,"height":487,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","type":"image\/png"}],"author":"Kim Morris","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Kim Morris","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/"},"author":{"name":"Kim Morris","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"headline":"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement","datePublished":"2020-05-21T17:59:35+00:00","dateModified":"2023-06-06T21:53:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/"},"wordCount":180,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","keywords":["2020"],"articleSection":["Infectious Diseases","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/","name":"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","datePublished":"2020-05-21T17:59:35+00:00","dateModified":"2023-06-06T21:53:30+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","width":350,"height":487,"caption":"Jonathan Parr, MD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/use-of-arthritis-drug-for-covid-19-lacks-clear-evidence-of-clinical-improvement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Use of Arthritis Drug For COVID-19 Lacks Clear Evidence of Clinical Improvement"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529","name":"Kim Morris","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","caption":"Kim Morris"},"description":"Medicine - Dept of","url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-216x300.png","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-150x150.png","featured_image_alt":"dr-jonathan-parr-STD-Awareness","category_details":[{"name":"Infectious Diseases","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/infectious-diseases\/"},{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"}],"tag_details":[{"name":"2020","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2020\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/41992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/69419"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=41992"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/41992\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/3504"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=41992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=41992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=41992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}